Staff Reporter

AEM Q1 profit surges fourfold to $14.3m on strong demand

AEM Q1 profit surges fourfold to $14.3m on strong demand

Revenue climbed 35.8% with stronger test solutions contribution and margin expansion.

Keppel Infra Trust sees 17.3% drop in Q1 income, underlying earnings jump

Excluding divestment gains, distributable income rose 18.2%YoY to $53.7m.

NTT DC REIT beats IPO forecast with $0.0708 DPU

Its maiden distribution was 2.6% above forecast, supported by higher revenue and lower finance costs.

Kimly’s net profit rises 10.6% to $16.4m in H1 FY2026

Revenue inched up on stronger contributions from its outlet management and investment divisions.

Singapore banks benefit from safe-haven flows amidst Middle East conflict

Investors are shifting assets to the city-state for stability and protection.

Daily Markets Briefing: STI up 1.17%; Top stock is Wilmar International

Seatrium Limited is the top stock with a 5.38% increase.

Why Singapore’s high-value pharma specialisation now a primary US target

This may weaken future biomedical investment into the city-state.

Azure fund manager Terence Wong emerges as Trek 2000 substantial shareholder

He is acquiring a 7.3% stake in the company through a married deal at $0.12 per share.

Ransomware made up 58% of cyber incidents in 2025

The firm warned that AI-driven scams and nation-state activity could heighten risks in 2026.

Singapore SMEs still rely on cash despite card-heavy e-commerce market

About 33% of SMEs reported high cash usage, even as cards dominate online payments.

Singapore workers less confident over job security than APAC peers

Only 15% strongly believe their job is safe from elimination.

Office sector dominates investment sales with 31.8% share in Q1

Overall investment sales climbed 14.3% on stronger deal activity across public and private markets.

GIC and Sony Music Publishing acquire 45,000-song catalogue

Blackstone exits catalogue as Sony-GIC venture expands music rights exposure across global assets.

Life insurance payouts hit $5.08b in Q1

Health claims added another $712m, mainly from Integrated Shield Plans.

Singapore and China broaden drug oversight deal to cover gene therapies

It alters regulatory pathway structure for emerging medical technologies.